Works matching AU Ishikawa, Toru

Results: 183

Impacts of metabolic syndrome diseases on long-term outcomes of chronic hepatitis B patients treated with nucleos(t)ide analogues.

Published in:

Clinical & Molecular Hepatology, 2025, v. 31, n. 3, p. 1003, doi. 10.3350/cmh.2024.1070

By:

Rui Huang;
Dae Won Jun;
Hidenori Toyoda;
Yao-Chun Hsu;
Trinh, Huy;
Akito Nozaki;
Toru Ishikawa;
Tsunamasa Watanabe;
Haruki Uojima;
Huang, Daniel Q.;
Takashi Honda;
Yasuhito Tanaka;
Vutien, Philip;
Marciano, Sebastián;
Hiroshi Abe;
Masaru Enomoto;
Masanori Atsukawa;
Hirokazu Takahashi;
Kunihiko Tsuji;
Koichi Takaguchi

Publication type:

Article

Clinical Impact of Serum CRP Levels on Advanced HCC Treated With Durvalumab and Tremelimumab: A Multicentre Study.

Published in:

Liver International, 2025, v. 45, n. 7, p. 1, doi. 10.1111/liv.70192

By:

Hatanaka, Takeshi;
Yata, Yutaka;
Hiraoka, Atsushi;
Tada, Toshifumi;
Hirooka, Masashi;
Kariyama, Kazuya;
Tani, Joji;
Atsukawa, Masanori;
Takaguchi, Koichi;
Itobayashi, Ei;
Kakizaki, Satoru;
Fukunishi, Shinya;
Tsuji, Kunihiko;
Ishikawa, Toru;
Tajiri, Kazuto;
Toyoda, Hidenori;
Koshiyama, Yuichi;
Ogawa, Chikara;
Nishikawa, Hiroki;
Nishimura, Takashi

Publication type:

Article

Impact of hepatocellular carcinoma aetiology and liver function on the benefit of surveillance: A novel approach for the adjustment of lead‐time bias.

Published in:

Liver International, 2018, v. 38, n. 12, p. 2260, doi. 10.1111/liv.13927

By:

Toyoda, Hidenori;
Kumada, Takashi;
Tada, Toshifumi;
Mizuno, Kazuyuki;
Hiraoka, Atsushi;
Tsuji, Kunihiko;
Ishikawa, Toru;
Akita, Tomoyuki;
Tanaka, Junko

Publication type:

Article

Electrochemical Na Insertion and Solid Electrolyte Interphase for Hard-Carbon Electrodes and Application to Na-Ion Batteries.

Published in:

Advanced Functional Materials, 2011, v. 21, n. 20, p. 3859, doi. 10.1002/adfm.201100854

By:

Komaba, Shinichi;
Murata, Wataru;
Ishikawa, Toru;
Yabuuchi, Naoaki;
Ozeki, Tomoaki;
Nakayama, Tetsuri;
Ogata, Atsushi;
Gotoh, Kazuma;
Fujiwara, Kazuya

Publication type:

Article

Factors Affecting an Increase in Spleen Volume and Association of Spleen Volume Variation with the Clinical Outcomes of Atezolizumab and Bevacizumab Treatment for Hepatocellular Carcinoma: A Retrospective Analysis.

Published in:

Oncology, 2025, v. 103, n. 2, p. 94, doi. 10.1159/000541002

By:

Hatanaka, Takeshi;
Saito, Naoto;
Kakizaki, Satoru;
Hiraoka, Atsushi;
Tada, Toshifumi;
Kariyama, Kazuya;
Tani, Joji;
Takaguchi, Koichi;
Itobayashi, Ei;
Ishikawa, Toru;
Toyoda, Hidenori;
Kawata, Kazuhito;
Naganuma, Atsushi;
Yata, Yutaka;
Ohama, Hideko;
Matono, Tomomitsu;
Tada, Fujimasa;
Nouso, Kazuhiro;
Morishita, Asahiro;
Tsutsui, Akemi

Publication type:

Article

Lenvatinib as Second-Line Treatment after Atezolizumab plus Bevacizumab for Unresectable Hepatocellular Carcinoma: Clinical Results Show Importance of Hepatic Reserve Function.

Published in:

Oncology, 2023, v. 101, n. 10, p. 624, doi. 10.1159/000531316

By:

Hiraoka, Atsushi;
Kumada, Takashi;
Tada, Toshifumi;
Hirooka, Masashi;
Kariyama, Kazuya;
Tani, Joji;
Atsukawa, Masanori;
Takaguchi, Koichi;
Itobayashi, Ei;
Fukunishi, Shinya;
Tsuji, Kunihiko;
Ishikawa, Toru;
Tajiri, Kazuto;
Ochi, Hironori;
Yasuda, Satoshi;
Toyoda, Hidenori;
Ogawa, Chikara;
Nishimura, Takashi;
Hatanaka, Takeshi;
Kakizaki, Satoru

Publication type:

Article

Comparison between Atezolizumab Plus Bevacizumab and Lenvatinib for Hepatocellular Carcinoma in Patients with Child-Pugh Class B in Real-World Clinical Settings.

Published in:

Oncology, 2023, v. 101, n. 9, p. 542, doi. 10.1159/000530028

By:

Ohama, Hideko;
Hiraoka, Atsushi;
Tada, Toshifumi;
Hirooka, Masashi;
Kariyama, Kazuya;
Tani, Joji;
Atsukawa, Masanori;
Takaguchi, Koichi;
Itobayashi, Ei;
Fukunishi, Shinya;
Tsuji, Kunihiko;
Ishikawa, Toru;
Tajiri, Kazuto;
Ochi, Hironori;
Yasuda, Satoshi;
Toyoda, Hidenori;
Ogawa, Chikara;
Nishimura, Takashi;
Hatanaka, Takeshi;
Kakizaki, Satoru

Publication type:

Article

Nutritional Status Is Associated with Prognosis in Patients with Advanced Unresectable Hepatocellular Carcinoma Treated with Atezolizumab plus Bevacizumab.

Published in:

Oncology, 2023, v. 101, n. 4, p. 270, doi. 10.1159/000527676

By:

Tada, Toshifumi;
Kumada, Takashi;
Hiraoka, Atsushi;
Kariyama, Kazuya;
Tani, Joji;
Hirooka, Masashi;
Takaguchi, Koichi;
Atsukawa, Masanori;
Fukunishi, Shinya;
Itobayashi, Ei;
Tsuji, Kunihiko;
Tajiri, Kazuto;
Ochi, Hironori;
Ishikawa, Toru;
Yasuda, Satoshi;
Ogawa, Chikara;
Toyoda, Hidenori;
Hatanaka, Takeshi;
Nishimura, Takashi;
Kakizaki, Satoru

Publication type:

Article

Clinical Predictor of Urinary Protein as Adverse Event Associated with Atezolizumab plus Bevacizumab Treatment for Unresectable Hepatocellular Carcinoma.

Published in:

Oncology, 2022, v. 100, n. 12, p. 645, doi. 10.1159/000526521

By:

Hiraoka, Atsushi;
Kumada, Takashi;
Tada, Toshifumi;
Hirooka, Masashi;
Kariyama, Kazuya;
Tani, Joji;
Atsukawa, Masanori;
Takaguchi, Koichi;
Itobayashi, Ei;
Fukunishi, Shinya;
Tsuji, Kunihiko;
Ishikawa, Toru;
Tajiri, Kazuto;
Ochi, Hironori;
Yasuda, Satoshi;
Toyoda, Hidenori;
Ogawa, Chikara;
Nishimura, Takashi;
Hatanaka, Takeshi;
Kakizaki, Satoru

Publication type:

Article

Simple Scoring System for Predicting TACE Unsuitable among Intermediate-Stage Hepatocellular Carcinoma Patients in the Multiple Systemic Treatment Era.

Published in:

Oncology, 2022, v. 100, n. 2, p. 65, doi. 10.1159/000520292

By:

Hiraoka, Atsushi;
Kumada, Takashi;
Kariyama, Kazuya;
Toyoda, Hidenori;
Yasuda, Satoshi;
Tsuji, Kunihiko;
Hatanaka, Takeshi;
Kakizaki, Satoru;
Naganuma, Atsushi;
Ishikawa, Toru;
Tada, Toshifumi;
Takaguchi, Koichi;
Itobayashi, Ei;
Shimada, Noritomo;
Shibata, Hiroshi;
Tanaka, Takaaki;
Tsutsui, Akemi;
Nagano, Takuya;
Imai, Michitaka;
Nakamura, Shinichiro

Publication type:

Article

Impact of Early Lenvatinib Administration on Survival in Patients with Intermediate-Stage Hepatocellular Carcinoma: A Multicenter, Inverse Probability Weighting Analysis.

Published in:

Oncology, 2021, v. 99, n. 8, p. 518, doi. 10.1159/000515896

By:

Tada, Toshifumi;
Kumada, Takashi;
Hiraoka, Atsushi;
Michitaka, Kojiro;
Atsukawa, Masanori;
Hirooka, Masashi;
Tsuji, Kunihiko;
Ishikawa, Toru;
Takaguchi, Koichi;
Kariyama, Kazuya;
Itobayashi, Ei;
Tajiri, Kazuto;
Shimada, Noritomo;
Shibata, Hiroshi;
Ochi, Hironori;
Yasuda, Satoshi;
Toyoda, Hidenori;
Fukunishi, Shinya;
Ohama, Hideko;
Kawata, Kazuhito

Publication type:

Article

Nutritional Index as Prognostic Indicator in Patients Receiving Lenvatinib Treatment for Unresectable Hepatocellular Carcinoma.

Published in:

Oncology, 2020, v. 98, n. 5, p. 295, doi. 10.1159/000506293

By:

Hiraoka, Atsushi;
Kumada, Takashi;
Tada, Toshifumi;
Fukunishi, Shinya;
Atsukawa, Masanori;
Hirooka, Masashi;
Tsuji, Kunihiko;
Ishikawa, Toru;
Takaguchi, Koichi;
Kariyama, Kazuya;
Itobayashi, Ei;
Tajiri, Kazuto;
Shimada, Noritomo;
Shibata, Hiroshi;
Ochi, Hironori;
Kawata, Kazuhito;
Toyoda, Hidenori;
Ohama, Hideko;
Tsutsui, Akemi;
Itokawa, Norio

Publication type:

Article

Early Relative Change in Hepatic Function with Lenvatinib for Unresectable Hepatocellular Carcinoma.

Published in:

Oncology, 2019, v. 97, n. 6, p. 334, doi. 10.1159/000502095

By:

Hiraoka, Atsushi;
Kumada, Takashi;
Atsukawa, Masanori;
Hirooka, Masashi;
Tsuji, Kunihiko;
Ishikawa, Toru;
Takaguchi, Koichi;
Kariyama, Kazuya;
Itobayashi, Ei;
Tajiri, Kazuto;
Shimada, Noritomo;
Shibata, Hiroshi;
Ochi, Hironori;
Tada, Toshifumi;
Toyoda, Hidenori;
Nouso, Kazuhiro;
Tsutsui, Akemi;
Nagano, Takuya;
Itokawa, Norio;
Hayama, Korenobu

Publication type:

Article

Important Clinical Factors in Sequential Therapy Including Lenvatinib against Unresectable Hepatocellular Carcinoma.

Published in:

Oncology, 2019, v. 97, n. 5, p. 277, doi. 10.1159/000501281

By:

Hiraoka, Atsushi;
Kumada, Takashi;
Atsukawa, Masanori;
Hirooka, Masashi;
Tsuji, Kunihiko;
Ishikawa, Toru;
Takaguchi, Koichi;
Kariyama, Kazuya;
Itobayashi, Ei;
Tajiri, Kazuto;
Shimada, Noritomo;
Shibata, Hiroshi;
Ochi, Hironori;
Tada, Toshifumi;
Toyoda, Hidenori;
Nouso, Kazuhiro;
Tsutsui, Akemi;
Nagano, Takuya;
Itokawa, Norio;
Hayama, Korenobu

Publication type:

Article

Proposed New Sub-Grouping for Intermediate-Stage Hepatocellular Carcinoma Using Albumin-Bilirubin Grade.

Published in:

Oncology, 2016, v. 91, n. 3, p. 153, doi. 10.1159/000447061

By:

Hiraoka, atsushi;
Kumada, Takashi;
Nouso, Kazuhiro;
Tsuji, Kunihiko;
Itobayashi, Ei;
Hirooka, Masashi;
Kariyama, Kazuya;
Ishikawa, Toru;
Tada, Toshifumi;
Toyoda, Hidenori;
Kawasaki, Hideki;
Hiasa, Yoichi;
Michitaka, Kojiro

Publication type:

Article

Characteristics of cabozantinib treatment in advanced hepatocellular carcinoma.

Published in:

Liver Cancer International, 2023, v. 4, n. 3, p. 101, doi. 10.1002/lci2.74

By:

Nouso, Kazuhiro;
Shiota, Shohei;
Fujita, Rio;
Wakuta, Akiko;
Kariyama, Kazuya;
Hiraoka, Atsushi;
Atsukawa, Masanori;
Tani, Joji;
Tada, Toshifumi;
Matsuo, Yu;
Nakamura, Shinichiro;
Tajiri, Kazuto;
Kaibori, Masaki;
Hirooka, Masashi;
Itobayashi, Ei;
Kakizaki, Satoru;
Naganuma, Atsushi;
Ishikawa, Toru;
Hatanaka, Takeshi;
Fukunishi, Shinya

Publication type:

Article

Suppression of popping rates in radiofrequency ablation under perfluorobutane microbubbles for hepatocellular carcinoma.

Published in:

Clinical & Experimental Hepatology, 2024, v. 10, n. 4, p. 257, doi. 10.5114/ceh.2024.145451

By:

Toru Ishikawa;
Hiroshi Hirosawa;
Tsubasa Honmou;
Iori Hasegawa;
Nobuyuki Sakai;
Ryo Sato;
Ryo Jimbo;
Yuji Kobayashi;
Toshifumi Sato;
Akito Iwanaga;
Tomoe Sano;
Junji Yokoyama;
Terasu Honma

Publication type:

Article

Optimal Skeletal Muscle Mass Index Cut-Off Values for Presarcopenia Evaluated by Computed Tomography against Dual-Energy X-ray Absorptiometry in Patients with Chronic Liver Disease.

Published in:

Journal of Clinical Medicine, 2021, v. 10, n. 7, p. 1419, doi. 10.3390/jcm10071419

By:

Ohashi, Kazuki;
Ishikawa, Toru;
Hoshii, Asami;
Hokari, Tamaki;
Noguchi, Hirohito;
Suzuki, Mitsuyuki;
Hirosawa, Hiroshi;
Imai, Michitaka;
Mitobe, Yuta;
Yoshida, Toshiaki;
Nishikawa, Hiroki

Publication type:

Article

Preferences for Floor Plans of Medium-Sized Apartments: A Survey Analysis in Beijing, China.

Published in:

Housing Studies, 2013, v. 28, n. 3, p. 429, doi. 10.1080/02673037.2013.759542

By:

Gao, Xiaolu;
Asami, Yasushi;
Zhou, Yanmin;
Ishikawa, Toru

Publication type:

Article

A Phase 2, Prospective, Multicenter, Single-Arm Trial of Transarterial Chemoembolization Therapy in Combination Strategy with Lenvatinib in Patients with Unresectable Intermediate-Stage Hepatocellular Carcinoma: TACTICS-L Trial.

Published in:

Liver Cancer (2235-1795), 2024, v. 13, n. 1, p. 99, doi. 10.1159/000531377

By:

Kudo, Masatoshi;
Ueshima, Kazuomi;
Saeki, Issei;
Ishikawa, Toru;
Inaba, Yoshitaka;
Morimoto, Naoki;
Aikata, Hiroshi;
Tanabe, Nobukazu;
Wada, Yoshiyuki;
Kondo, Yasuteru;
Tsuda, Masahiro;
Nakao, Kazuhiko;
Ito, Takanori;
Hosaka, Tetsuya;
Kawamura, Yusuke;
Kuzuya, Teiji;
Nojiri, Shunsuke;
Ogawa, Chikara;
Koga, Hironori;
Hino, Keisuke

Publication type:

Article

Attempt to Establish Prognostic Predictive System for Hepatocellular Carcinoma Using Artificial Intelligence for Assistance with Selection of Treatment Modality.

Published in:

Liver Cancer (2235-1795), 2023, v. 12, n. 6, p. 565, doi. 10.1159/000530078

By:

Hiraoka, Atsushi;
Kumada, Takashi;
Tada, Toshifumi;
Toyoda, Hidenori;
Kariyama, Kazuya;
Hatanaka, Takeshi;
Kakizaki, Satoru;
Naganuma, Atsushi;
Itobayashi, Ei;
Tsuji, Kunihiko;
Ishikawa, Toru;
Ohama, Hideko;
Tada, Fujimasa;
Nouso, Kazuhiro

Publication type:

Article

Relationship of Atezolizumab plus Bevacizumab Treatment with Muscle Volume Loss in Unresectable Hepatocellular Carcinoma Patients: Multicenter Analysis.

Published in:

Liver Cancer (2235-1795), 2023, v. 12, n. 3, p. 209, doi. 10.1159/000527402

By:

Hiraoka, Atsushi;
Kumada, Takashi;
Tada, Toshifumi;
Hirooka, Masashi;
Kariyama, Kazuya;
Tani, Joji;
Atsukawa, Masanori;
Takaguchi, Koichi;
Itobayashi, Ei;
Fukunishi, Shinya;
Tsuji, Kunihiko;
Ishikawa, Toru;
Tajiri, Kazuto;
Ochi, Hironori;
Yasuda, Satoshi;
Toyoda, Hidenori;
Ogawa, Chikara;
Nishimura, Takashi;
Hatanaka, Takeshi;
Kakizaki, Satoru

Publication type:

Article

What Can Be Done to Solve the Unmet Clinical Need of Hepatocellular Carcinoma Patients following Lenvatinib Failure?

Published in:

Liver Cancer (2235-1795), 2021, v. 10, n. 2, p. 115, doi. 10.1159/000513355

By:

Atsushi Hiraoka;
Takashi Kumada;
Toshifumi Tada;
Kazuya Kariyama;
Joji Tani;
Shinya Fukunishi;
Masanori Atsukawa;
Masashi Hirooka;
Kunihiko Tsuji;
Toru Ishikawa;
Koichi Takaguchi;
Ei Itobayashi;
Kazuto Tajiri;
Noritomo Shimada;
Hiroshi Shibata;
Hironori Ochi;
Kazuhito Kawata;
Satoshi Yasuda;
Hidenori Toyoda;
Hideko Ohama

Publication type:

Article

EZ-ALBI Score for Predicting Hepatocellular Carcinoma Prognosis.

Published in:

Liver Cancer (2235-1795), 2020, v. 9, n. 6, p. 734, doi. 10.1159/000508971

By:

Kariyama, Kazuya;
Nouso, Kazuhiro;
Hiraoka, Atsushi;
Wakuta, Akiko;
Oonishi, Ayano;
Kuzuya, Teiji;
Toyoda, Hidenori;
Tada, Toshifumi;
Tsuji, Kunihiko;
Itobayashi, Ei;
Ishikawa, Toru;
Takaguchi, Koichi;
Tsutsui, Akemi;
Shimada, Noritomo;
Kudo, Masatoshi;
Kumada, Takashi

Publication type:

Article

Post-Progression Treatment Eligibility of Unresectable Hepatocellular Carcinoma Patients Treated with Lenvatinib.

Published in:

Liver Cancer (2235-1795), 2020, v. 9, n. 1, p. 73, doi. 10.1159/000503031

By:

Hiraoka, Atsushi;
Kumada, Takashi;
Fukunishi, Shinya;
Atsukawa, Masanori;
Hirooka, Masashi;
Tsuji, Kunihiko;
Ishikawa, Toru;
Takaguchi, Koichi;
Kariyama, Kazuya;
Itobayashi, Ei;
Tajiri, Kazuto;
Shimada, Noritomo;
Shibata, Hiroshi;
Ochi, Hironori;
Tada, Toshifumi;
Toyoda, Hidenori;
Yokohama, Keisuke;
Nouso, Kazuhiro;
Tsutsui, Akemi;
Nagano, Takuya

Publication type:

Article

Treatment of Intermediate-Stage Hepatocellular Carcinoma in Japan: Position of Curative Therapies.

Published in:

Liver Cancer (2235-1795), 2020, v. 9, n. 1, p. 41, doi. 10.1159/000502479

By:

Kariyama, Kazuya;
Nouso, Kazuhiro;
Wakuta, Akiko;
Oonishi, Ayano;
Toyoda, Hidenori;
Tada, Toshifumi;
Hiraoka, Atsushi;
Tsuji, Kunihiko;
Itobayashi, Ei;
Ishikawa, Toru;
Takaguchi, Koichi;
Tsutsui, Akemi;
Shimada, Noritomo;
Kumada, Takashi

Publication type:

Article

Beneficial effect of oral semaglutide for type 2 diabetes mellitus in patients with metabolic dysfunction‐associated steatotic liver disease: A prospective, multicentre, observational study.

Published in:

Diabetes, Obesity & Metabolism, 2024, v. 26, n. 11, p. 4958, doi. 10.1111/dom.15898

By:

Arai, Taeang;
Atsukawa, Masanori;
Tsubota, Akihito;
Oikawa, Tsunekazu;
Tada, Toshifumi;
Matsuura, Kentaro;
Ishikawa, Toru;
Abe, Hiroshi;
Kato, Keizo;
Morishita, Asahiro;
Tani, Joji;
Okubo, Tomomi;
Nagao, Mototsugu;
Iwabu, Masato;
Iwakiri, Katsuhiko

Publication type:

Article

Predictive factors and survival outcome of conversion therapy for unresectable hepatocellular carcinoma patients receiving atezolizumab and bevacizumab: Comparative analysis of conversion, partial response and complete response patients.

Published in:

Alimentary Pharmacology & Therapeutics, 2024, v. 60, n. 10, p. 1361, doi. 10.1111/apt.18237

By:

Hatanaka, Takeshi;
Kakizaki, Satoru;
Hiraoka, Atsushi;
Tada, Toshifumi;
Hirooka, Masashi;
Kariyama, Kazuya;
Tani, Joji;
Atsukawa, Masanori;
Takaguchi, Koichi;
Itobayashi, Ei;
Fukunishi, Shinya;
Tsuji, Kunihiko;
Ishikawa, Toru;
Tajiri, Kazuto;
Toyoda, Hidenori;
Ogawa, Chikara;
Nishikawa, Hiroki;
Nishimura, Takashi;
Kawata, Kazuhito;
Kosaka, Hisashi

Publication type:

Article

Outcomes of patients with hepatocellular carcinoma treated with atezolizumab plus bevacizumab in real‐world clinical practice who met or did not meet the inclusion criteria for the phase 3 IMbrave150 trial.

Published in:

Alimentary Pharmacology & Therapeutics, 2024, v. 60, n. 2, p. 233, doi. 10.1111/apt.18037

By:

Tada, Toshifumi;
Kumada, Takashi;
Hiraoka, Atsushi;
Hirooka, Masashi;
Kariyama, Kazuya;
Tani, Joji;
Atsukawa, Masanori;
Takaguchi, Koichi;
Itobayashi, Ei;
Fukunishi, Shinya;
Nishikawa, Hiroki;
Tsuji, Kunihiko;
Ishikawa, Toru;
Tajiri, Kazuto;
Koshiyama, Yuichi;
Toyoda, Hidenori;
Ogawa, Chikara;
Hatanaka, Takeshi;
Kakizaki, Satoru;
Kawata, Kazuhito

Publication type:

Article

Perception and Conceptualization of House Floor Plans: An Experimental Analysis.

Published in:

Environment & Behavior, 2011, v. 43, n. 2, p. 233, doi. 10.1177/0013916509356874

By:

Ishikawa, Toru;
Nakata, Saya;
Asami, Yasushi

Publication type:

Article

An experimental analysis of the perception of the area of an open space using 3-D stereo dynamic...

Published in:

Environment & Behavior, 1998, v. 30, n. 2, p. 216, doi. 10.1177/0013916598302005

By:

Ishikawa, Toru;
Okabe, Atsuyuki;
Sadahiro, Yukio;
Kakumoto, Shigeru

Publication type:

Article

Intraoperative Facial Nerve Monitoring Revealed the Origin of Rapidly Progressing Schwannoma in the Cerebellopontine Angle: A Case of Large Intermediate Nerve Schwannoma.

Published in:

Journal of International Advanced Otology, 2018, v. 14, n. 3, p. 488, doi. 10.5152/iao.2018.5542

By:

Makoto Hosoya;
Naoki Oishi;
Masaru Noguchi;
Kento Kasuya;
Takanori Nishiyama;
Toru Ishikawa;
Ken Kasahara;
Hidemi Miyazaki;
Kaoru Ogawa

Publication type:

Article

Longitudinal increase in albumin–bilirubin score is associated with non-malignancy-related mortality and quality of life in patients with liver cirrhosis.

Published in:

PLoS ONE, 2022, v. 17, n. 2, p. 1, doi. 10.1371/journal.pone.0263464

By:

Sakamaki, Akira;
Takamura, Masaaki;
Sakai, Norihiro;
Watanabe, Yusuke;
Arao, Yoshihisa;
Kimura, Naruhiro;
Setsu, Toru;
Abe, Hiroyuki;
Yokoo, Takeshi;
Kamimura, Hiroteru;
Tsubata, Shunsuke;
Waguri, Nobuo;
Ishikawa, Toru;
Kawai, Hirokazu;
Sugitani, Soichi;
Sato, Tomomi;
Funakoshi, Kazuhiro;
Watanabe, Masashi;
Igarashi, Kentarou;
Kamimura, Kenya

Publication type:

Article

Complete Remission of Multiple Hepatocellular Carcinomas Associated With Hepatitis C Virus- Related, Decompensated Liver Cirrhosis by Oral Administration of Enteric-Coated Tegafur/Uracil.

Published in:

American Journal of Gastroenterology (Springer Nature), 1999, v. 94, n. 6, p. 1682, doi. 10.1111/j.1572-0241.1999.01163.x

By:

Ishikawa, Toru;
Ichida, Takafumi;
Ishimoto, Yuiko;
Yokoyama, Junji;
Nomoto, Minoru;
Ebe, Yusuke;
Usuda, Hiroyuki;
Naito, Makoto;
Asakura, Hitoshi

Publication type:

Article

Effects of mineralocorticoid receptor antagonists on sex hormones and body composition in patients with primary aldosteronism.

Published in:

Hypertension Research, 2022, v. 45, n. 3, p. 496, doi. 10.1038/s41440-021-00836-6

By:

Ishikawa, Toru;
Morimoto, Satoshi;
Ichihara, Atsuhiro

Publication type:

Article

Comparison of the usefulness of the cardio-ankle vascular index and augmentation index as an index of arteriosclerosis in patients with essential hypertension.

Published in:

Hypertension Research, 2022, v. 45, n. 3, p. 455, doi. 10.1038/s41440-021-00823-x

By:

Ishida, Kazuya;
Morimoto, Satoshi;
Horiuchi, Sayuri;
Kimura, Miwa;
Ishikawa, Toru;
Kimura, Shihori;
Yamashita, Kaoru;
Takano, Noriyoshi;
Seki, Yasufumi;
Bokuda, Kanako;
Sasaki, Nobukazu;
Watanabe, Daisuke;
Ichihara, Atsuhiro

Publication type:

Article

Role of hepatic resection in patients with intermediate-stage hepatocellular carcinoma: A multicenter study from Japan.

Published in:

Cancer Science, 2017, v. 108, n. 7, p. 1414, doi. 10.1111/cas.13257

By:

Tada, Toshifumi;
Kumada, Takashi;
Toyoda, Hidenori;
Tsuji, Kunihiko;
Hiraoka, Atsushi;
Itobayashi, Ei;
Nouso, Kazuhiro;
Kariyama, Kazuya;
Ishikawa, Toru;
Hirooka, Masashi;
Hiasa, Yoichi

Publication type:

Article

Impact of Li Ion Transport Properties on Reversibility of Li Metal Electrode in Glyme‐Based Electrolytes.

Published in:

ChemElectroChem, 2024, v. 11, n. 14, p. 1, doi. 10.1002/celc.202400054

By:

Murai, Junichi;
Ishikawa, Toru;
Wada, Gakuto;
Dokko, Kaoru;
Watanabe, Masayoshi;
Ueno, Kazuhide

Publication type:

Article

Health-related quality of life on the clinical course of patients with chronic hepatitis C receiving daclatasvir/asunaprevir therapy: A prospective observational study comparing younger (<70) and elderly (≥70) patients.

Published in:

Experimental & Therapeutic Medicine, 2018, v. 15, n. 1, p. 970, doi. 10.3892/etm.2017.5488

By:

Ohashi, Kazuki;
Ishikawa, Toru;
Suzuki, Mitsuyuki;
Abe, Hiroko;
Koyama, Fujiko;
Nakano, Tomomi;
Ueki, Aya;
Noguchi, Hirohito;
Hasegawa, Erina;
Hirosawa, Shiori;
Kobayashi, Miki;
Hirosawa, Hiroshi;
Sato, Kaede;
Fukazawa, Takako;
Maruyama, Yuka;
Yoshida, Toshiaki

Publication type:

Article

Evaluation of the health-related quality of life using the 36-item short form health survey in patients with chronic hepatitis C receiving pegylated interferon/ribavirin/telaprevir triple treatment.

Published in:

Experimental & Therapeutic Medicine, 2016, v. 12, n. 5, p. 3353, doi. 10.3892/etm.2016.3785

By:

MITSUYUKI SUZUKI;
TORU ISHIKAWA;
AI SAKUMA;
SATOSHI ABE;
HIROKO ABE;
FUJIKO KOYAMA;
TOMOMI NAKANO;
AYA UEKI;
HIROHITO NOGUCHI;
ERINA HASEGAWA;
SHIORI YAMAGATA;
MIKI KOBAYASHI;
KAZUTAKA OHASHI;
HIROSHI HIROSAWA;
TAKAKO FUKAZAWA;
YUKA MARUYAMA;
TOSHIAKI YOSHIDA

Publication type:

Article

Telaprevir-based triple therapy following partial splenic arterial embolization for chronic hepatitis C with thrombocytopenia can reduce carcinogenesis and improve hepatic function reserve.

Published in:

Experimental & Therapeutic Medicine, 2015, v. 10, n. 4, p. 1334, doi. 10.3892/etm.2015.2674

By:

TORU ISHIKAWA;
SATOSHI ABE;
YUICHI KOJIMA;
RYOKO HORIGOME;
TOMOE SANO;
AKITO IWANAGA;
KEIICHI SEKI;
TERASU HONMA;
TOSHIAKI YOSHIDA

Publication type:

Article

Prediction of a sustained viral response in chronic hepatitis C patients who undergo induction therapy with double filtration plasmapheresis plus interferon-β/ribavirin.

Published in:

Experimental & Therapeutic Medicine, 2015, v. 9, n. 5, p. 1646, doi. 10.3892/etm.2015.2340

By:

TORU ISHIKAWA;
SATOSHI ABE;
YUICHI KOJIMA;
TOMOE SANO;
AKITO IWANAGA;
KEI-ICHI SEKI;
TERASU HONMA;
TOSHIAKI YOSHIDA;
MIHOKO YAMAZAKI;
TAKEHITO SAKAI;
KAZUYUKI TASAKI;
YASUSHI SUZUKI

Publication type:

Article

Percutaneous transhepatic obliteration and percutaneous transhepatic sclerotherapy for intractable hepatic encephalopathy and gastric varices improves the hepatic function reserve.

Published in:

Biomedical Reports, 2017, v. 6, n. 1, p. 99, doi. 10.3892/br.2016.811

By:

TORU ISHIKAWA;
MICHITAKA IMAI;
MASAYOSHI KO;
HIROKI SATO;
YUJIRO NOZAWA;
TOMOE SANO;
AKITO IWANAGA;
KEIICHI SEKI;
TERASU HONMA;
TOSHIAKI YOSHIDA

Publication type:

Article

Clinical efficacy of the highly sensitive hepatitis C virus RNA quantitative assay in patients with relapse following interferon-based therapy with second-generation direct-acting antivirals.

Published in:

Biomedical Reports, 2016, v. 4, n. 6, p. 664, doi. 10.3892/br.2016.660

By:

TORU ISHIKAWA;
SATOSHI ABE;
TAKAYUKI WATANABE;
YUJIRO NOZAWA;
TOMOE SANO;
AKITO IWANAGA;
KEIICHI SEKI;
TERASU HONMA;
TOSHIAKI YOSHIDA

Publication type:

Article

Prognostic factor of lenvatinib for unresectable hepatocellular carcinoma in real‐world conditions—Multicenter analysis.

Published in:

Cancer Medicine, 2019, v. 8, n. 8, p. 3719, doi. 10.1002/cam4.2241

By:

Hiraoka, Atsushi;
Kumada, Takashi;
Atsukawa, Masanori;
Hirooka, Masashi;
Tsuji, Kunihiko;
Ishikawa, Toru;
Takaguchi, Koichi;
Kariyama, Kazuya;
Itobayashi, Ei;
Tajiri, Kazuto;
Shimada, Noritomo;
Shibata, Hiroshi;
Ochi, Hironori;
Tada, Toshifumi;
Toyoda, Hidenori;
Nouso, Kazuhiro;
Tsutsui, Akemi;
Nagano, Takuya;
Itokawa, Norio;
Hayama, Korenobu

Publication type:

Article

Clinical features of lenvatinib for unresectable hepatocellular carcinoma in real‐world conditions: Multicenter analysis.

Published in:

Cancer Medicine, 2019, v. 8, n. 1, p. 137, doi. 10.1002/cam4.1909

By:

Hiraoka, Atsushi;
Kumada, Takashi;
Kariyama, Kazuya;
Takaguchi, Koichi;
Atsukawa, Masanori;
Itobayashi, Ei;
Tsuji, Kunihiko;
Tajiri, Kazuto;
Hirooka, Masashi;
Shimada, Noritomo;
Shibata, Hiroshi;
Ishikawa, Toru;
Ochi, Hironori;
Tada, Toshifumi;
Toyoda, Hidenori;
Nouso, Kazuhiro;
Tsutsui, Akemi;
Itokawa, Norio;
Imai, Michitaka;
Joko, Kouji

Publication type:

Article

Geriatric nutritional risk index and newly developed scoring system as prognosis prediction for unresectable hepatocellular carcinoma patients treated with lenvatinib.

Published in:

Scientific Reports, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41598-024-78539-4

By:

Ohama, Hideko;
Hiraoka, Atsushi;
Tada, Toshifumi;
Hirooka, Masashi;
Kariyama, Kazuya;
Tani, Joji;
Atsukawa, Masanori;
Takaguchi, Koichi;
Itobayashi, Ei;
Fukunishi, Shinya;
Tsuji, Kunihiko;
Ishikawa, Toru;
Tajiri, Kazuto;
Ochi, Hironori;
Yasuda, Satoshi;
Toyoda, Hidenori;
Ogawa, Chikara;
Nishimura, Takashi;
Hatanaka, Takeshi;
Kakizaki, Satoru

Publication type:

Article

Complete disappearance of pulmonary metastases in a case of hepatocellular carcinoma treated with docetaxel-based systemic chemotherapy.

Published in:

Journal of Gastroenterology & Hepatology, 2004, v. 19, n. 12, p. 1423, doi. 10.1111/j.1440-1746.2004.03737.x

By:

Ishikawa, Toru;
Ichida, Takafumi;
Yokoyama, Junji;
Matsuda, Yasunobu;
Watanabe, Toshiaki;
Asakura, Hitoshi

Publication type:

Article

Systemic administration of liposome-encapsulated OK-432 prolongs the survival of rats with hepatocellular carcinoma through the induction of IFN-γ -producing hepatic lymphocytes.

Published in:

Journal of Gastroenterology & Hepatology, 2002, v. 17, n. 1, p. 81, doi. 10.1046/j.1440-1746.2002.02675.x

By:

UEHARA, KAZUHIRO;
ICHIDA, TAKAFUMI;
SUGAHARA, SATOSHI;
ISHIKAWA, TORU;
YAMAGIWA, SATOSHI;
YOSHIDA, YUHEI;
NOMOTO, MINORU;
KATOH, MASASHI;
SATOH, HIROSHI;
WATANABE, HISAMI;
ABO, TORU;
ASAKURA, HITOSHI

Publication type:

Article

High viral loads, serum alanine aminotransferase and gender are predictive factors for the development of hepatocellular carcinoma from viral compensated liver cirrhosis.

Published in:

Journal of Gastroenterology & Hepatology, 2001, v. 16, n. 11, p. 1274, doi. 10.1046/j.1440-1746.2001.02616.x

By:

Ishikawa, Toru;
Ichida, Takafumi;
Yamagiwa, Satoshi;
Sugahara, Satoshi;
Uehara, Kazuhiro;
Okoshi, Shogo;
Asakura, Hitoshi

Publication type:

Article